Participated · Equity · Sep 2018

Founded in 2015 by Harjinder Sandhu, Saykara offers a voice- and AI-powered mobile application that lets clinicians interact with electronic medical record (EMR) systems by voice. The company is commercially available and is live at several mid-size and large healthcare systems nationwide. Saykara is based in Seattle, WA and was founded by a former Nuance executive and machine learning veteran. It raised $5M in the reported funding round and intends to use the proceeds to continue expanding operations and development efforts. The round brings additional strategic backing from healthcare and venture investors and includes an accompanying board appointment.

Participated · Series B · May 2018

Qventus provides AI-based software that automates care operations across operating room and inpatient settings. The platform integrates with EHRs and leverages Generative AI, machine learning, and behavioral science to predict operational bottlenecks, recommend remedies, and automate processes. Its core offerings include Surgical Growth/Perioperative and Inpatient Capacity solutions that help care teams optimize patient flow and reduce cognitive load. In the last year its Inpatient Solution eliminated over 36,000 excess days for health system partners, saving them millions, and its Perioperative Solution generated $95M in annualized contribution margin in 2024 through Qventus-enabled cases. Led by CEO Mudit Garg and founded in 2012, the company intends to expand its AI Operational Assistants into new care settings beyond its current solutions. It plans to use recent funding to accelerate development and commercialization of those solutions. Qventus offers an AI-based SaaS platform purpose-built to automate care operations, integrating with EHRs and using AI, machine learning, and behavioral science. Its solutions target inpatient, perioperative, emergency department, and command center functions to improve operational workflows. The company partners with leading health systems, including Boston Medical Center, HonorHealth, M Health Fairview, Mercy, and Saint Luke’s Health System. Qventus is led by co-founder and CEO Mudit Garg and continues to expand its footprint across U.S. hospitals. Financially, the company recently attracted outside funding, including a $3M investment tied to prior growth financing announced in February 2022. Qventus provides AI-based software for care operations automation that integrates with EHRs. The platform uses AI, machine learning, and behavioral science to power practice solutions for inpatient, perioperative, emergency department, and command center settings. It partners with health systems including Boston Medical Center, HonorHealth, M Health Fairview, Mercy, and Saint Luke's Health System. Reported outcomes include fewer excess days, reductions in length of stay, and new cases added per operating room per month. The company is led by CEO Mudit Garg. Qventus plans to use the funding to expand its technology to additional hospitals and health systems across the United States. Qventus offers an AI/ML-driven software platform that streamlines and automates hospital workflows to improve flow, throughput and patient experience across emergency departments, perioperative areas, inpatient units, pharmacy and outpatient access. The platform acts as a “System of Action,” combining data, technology and people to enable real-time decision making and collaborative issue mitigation. Qventus provides modular capabilities for ED flow, perioperative scheduling, inpatient operations, patient safety and pharmacy operations. The company reports deployments at major U.S. health systems including NewYork-Presbyterian, Emory Healthcare and the Mercy health system, and its software has enabled more than 3.8M patient encounters to date. Qventus is based in Silicon Valley/Mountain View and plans to use new capital to continue rapid expansion of its AI-based platform across health systems. analyticsMD, based in Mountain View, CA and led by CEO Mudit Garg, provides an AI-powered hospital operations software platform. The platform collects large amounts of messy healthcare data, processes it in real time to predict issues and outcomes, and recommends immediate course-corrections that are sent to frontline teams. It addresses operational challenges across emergency departments, perioperative areas, inpatient and outpatient settings. The software is used by community, academic and public hospitals including Lucile Packard Children’s Hospital Stanford, El Camino Hospital, Sutter Auburn Faith Hospital, St. Joseph’s Medical Center, Medstar Montgomery Medical Center, Natividad Medical Center and Mercy. analyticsMD plans to use new funding for product development and to accelerate delivery of its AI platform to U.S. health systems.

Participated · Series B · Nov 2017

Arterys is a San Francisco, CA-based global medical imaging platform that delivers clinical AI products over the internet. Led by co-founder and acting CEO John Axerio-Cilies, the company provides a web-based, AI-powered, FDA-cleared cloud-native viewer and platform. It operates a marketplace and ecosystem of partners to develop and deliver clinical applications built on its platform. The company raised $28m in a Series C to broaden that ecosystem and accelerate partner efforts. Arterys plans to extend its proprietary technology to application partners to make it easier for clinicians to integrate AI into their workflows from a single interface. The company emphasizes accelerating partners’ efforts to bring new clinical-grade AI applications to providers through its platform. Arterys is a San Francisco-based provider of a web-based AI platform for medical image analytics that enables physicians to process patient imaging cases with embedded AI algorithms. The cloud platform supports MRI and CT and offers image interpretation, case sharing, and automated reporting. Its proprietary technology protects patient information and complies with U.S. and EU data privacy regulations. Arterys' Cardiac MRI suite was the first product of its kind to obtain FDA clearance for use as a diagnostic support tool and is also cleared in Canada and the EU. The platform and cardiac MRI suite have been used to help diagnose more than 15,000 patients worldwide. The company plans to use the new funding to expand its web-based AI platform, launch oncology and neurology products, and accelerate commercialization of its cardiac offering. Arterys develops deep-learning diagnostic software for medical imaging that connects to standard MRI machines to enable non-invasive, precise quantitation of blood flow. The cloud-based platform uploads 10-minute chest MRI scans to a HIPAA-compliant server for computation and presents results in a web browser for clinician interaction and rapid approval of quantitative analyses. The solution targets cardiovascular applications including structural heart disease, congenital heart disease, carotid/neurovascular and renal vascular disease. The company plans to expand commercial operations for its visualization and quantification algorithm using proceeds from its recent Series A. The platform has regulatory clearances—CE Mark and U.S. FDA market clearance (March 2014)—and is already used for research at leading hospitals in the U.S. and Europe. Arterys anticipates broader distribution through ViosWorks in up to 7,000 GE MRI machines in H2 2016; the company is led by founder and CEO Fabien Beckers.

Participated · Series A · Oct 2016

Avizia provides a telehealth platform that combines video devices with software to streamline care coordination, provider collaboration and patient engagement. Led by CEO and co-founder Mike Baird, the company's solutions include Avizia ONE, Avizia OnePass and myCare by Avizia. Its technology is deployed in 37 countries and is used by eight of the top ten hospital networks in the United States. Avizia has an enterprise-technology partnership with Northwell Health to align telehealth infrastructure across Northwell’s 21 hospitals and more than 550 outpatient practices in the New York metropolitan area. That alignment covers physician offices, imaging centers, laboratories, same-day surgical centers, skilled nursing facilities, home care, emergency medical and air ambulance services and enables virtual consults across the network. The company raised additional capital as part of its Series A, bringing that round's total to $18M. Avizia provides an end-to-end telehealth platform that combines video devices with software to streamline care coordination, provider collaboration, and patient engagement. Its solutions are deployed across more than 400 healthcare systems in 37 countries and in 8 of the top 10 U.S. hospital networks. Gartner lists Avizia as a sample vendor delivering an Enterprise Virtual Care Platform. The company says it will use new funding to expand engineering teams and its go-to-market reach to enhance telehealth offerings for hospitals and other providers. CEO and co-founder Mike Baird highlighted the goal of increasing access to care, improving quality, and lowering costs through technology-enabled services. Avizia builds an end-to-end telehealth platform that combines industry-leading video devices with software to streamline care coordination, provider collaboration, and patient engagement. The company delivers solutions to 37 of the top 100 U.S. healthcare IDNs, is deployed at hundreds of hospitals and clinics, and has sales in 36 countries. Founded in 2013, Avizia positions its platform to enable continuity of care by connecting any patient to any provider in any place. The company plans to use new funding to expand its telehealth video collaboration offerings for hospitals and physicians and to advance the patient experience. Avizia emphasizes bringing caregivers and family members into care conversations at the point of care to close coordination gaps. It announced an $11 million Series A to support continued innovation across its care coordination platform. Avizia is a telemedicine solution-provider that delivers a fully integrated telemedicine solution combining video devices, clinical workflow management, and HIPAA‑compliant communication software. The company sells packaged telemedicine offerings addressing telestroke, behavioral health, e-visits, and emergency care, integrating carts, peripherals, and connections to EHRs. Avizia announced a $4 million investment intended to accelerate sales, marketing, and product development. Investors named in the round include NextGen Angels, Waterline Ventures, and Middleland Capital; NextGen increased its investment after initially investing the prior fall. CEO Mike Baird said the company is experiencing faster-than-expected growth and will use the capital to expand the business to meet demand. The article cites a telemedicine market estimate of $5 billion over the next five years, supporting strong provider demand for packaged, seamless solutions. Avizia is a 1-year-old telemedicine technology company founded by former Cisco employee Michael Baird and based in Reston, Virginia. It builds telemedicine carts and high-definition screens that enable video consults between patients and specialists and between medical professionals. The company’s carts, unveiled at the American Telemedicine Association conference, use camera technology from Cisco’s Telepresence SX series. Avizia is pushing to grow its product line and expand its sales team across healthcare and education. As telemedicine gains acceptance, the company is positioning its hardware to improve access to and quality of patient care. The company reported a $2 million financing led by NextGen Angels with participation from Blu Venture Investors and Middleland Capital, and Edward Kennedy of Tollgrade Communication joined the board.